A Single-arm, Open-label Pilot Study to Evaluate the Feasibility of an Online-based Exercise Intervention for Outpatients with Cancer

未提供0 个研究点目标入组 15 人开始时间: 待定

适应症

试验速览

暂无简介。

•Eligible patients must meet ALL of the following:
•Histologically or cytologically confirmed diagnosis of any type of cancer.
•Clinical stage I or higher.
•Currently undergoing outpatient cancer treatment, or in an active follow-up phase within 5 years after diagnosis (regular imaging or blood tests at least once a year).
•Aged 18 years or older at the time of informed consent.
•ECOG Performance Status 0 to 2 and Karnofsky Performance Status 60% or higher.
•Owns and is willing/able to use an ICT device (smartphone or tablet).
•Has a safe space at home (or equivalent) for exercise: no protruding objects within 1.5 m radius, with a stable chair or wall available for support.
•Able to communicate effectively in Japanese.
•Provides written informed consent of their own free will.

•Patients meeting any of the following will be excluded:
•Estimated life expectancy of less than 3 months.
•Diagnosed with terminal cancer and currently receiving primarily palliative home nursing care.
•Any absolute contraindication to the intervention, including but not limited to: unstable angina or recent myocardial infarction (within 3 months); uncontrolled hypertension (resting SBP >180 mmHg or DBP >110 mmHg); severe aortic stenosis; acute systemic illness or fever; uncontrolled arrhythmia causing symptoms or hemodynamic instability; known meningeal carcinomatosis; spinal cord compression due to vertebral metastases with widespread advanced disease.
•Severe cognitive impairment that prevents understanding of instructions or safe participation.
•Refusal of regular hospital or outpatient visits, or consistently negative attitude, with no clearly scheduled next physician's appointment.
•Currently participating in another interventional clinical trial of similar nature.

发起方

未提供